Abstract Functional pasteurized fermented milk represents an important direction in dairy product development. This study investigated the alleviating effects and mechanisms of pasteurized fermented milks containing Bifidobacterium animalis subsp. Lactis ProbioM8, Lactobacillus paracasei PC01, and their combination on DSS‑induced IBD in mice. Metabolomics revealed that the pasteurized probiotic fermented milks were enriched in active metabolites such as organic acids and lipids, suggesting immunomodulatory potential. Animal experiments showed that they reduced the DAI and LPS levels, modulated inflammatory cytokines and oxidative stress, and repaired intestinal barrier damage. Further studies found that they restored gut microbiota dysbiosis and the levels of short‑chain fatty acids and tryptophan metabolites. Moreover, different fermented milks exhibited distinct pathway regulation: the Probio‑M8 and PC‑01 formulations activated the AMPK pathway, while the combination formulation inhibited pathways such as IL‑17 and TNF , thereby alleviating colitis.